Inserm at a Glance
Founded in 1964, Inserm is a public scientific and technological institute which operates under the joint authority of the French Ministries of Health and Research. The institute is dedicated to biomedical research and human health, and is involved in the entire range of activities from the laboratory to the patient’s bedside. It also partners with the most prestigious research institutions in the world that are committed to scientific challenges and progress in these fields.
Organization of the Institute
Chairman and Chief Executive Officer:
Didier Samuel
Vice-CEO for Strategy:
Thomas Lombès
Vice-CEO for Administration:
Damien Rousset
Executive Director:
Carine Delrieu
- 12 regional offices
- 9 theme-based instituts
Scientific production
Publications
Nearly 12,000 scientific publications in 2022, i.e.:
- 17% of French production, all fields of research combined
- 45% of French publications in the biological and medical field
Inserm is the 7th largest biomedical research organization in the world in terms of number of original articles published in 2022.
Value creation
Intellectual property
More than 2,300 active patent families, including 126 new families filed in 2022. Inserm is:
- 2nd European patent applicant in the pharmaceutical sector
- 2nd in the biotechnology category
- 7th French patent applicant, all organizations and sectors combined
Industrial partnerships
- 126 license agreements (patents, know-how, research tools)
- 307 non-consortium R&D contracts
Our Nobel and Lasker Prize winners
Nobel Prize
- Jean Dausset (1980)
- Françoise Barré-Sinoussi (2008)
Lasker Prize
- Étienne-Émile Baulieu (1989)
- Pierre Chambon (2004)
- Alim-Louis Benabid (2014)
Inserm in France
- 269 research units
- 48 service units
- 34 clinical investigation centers
and in the world
- 2 international mixed units
- 43 foreign laboratories within a theme-based coordination program, an international research project or network
- 7,000 declared international cooperation agreements with 106 countries
Workforce
- 5,025 civil servants, including:
- 2,166 researchers
- 2,859 engineers and technicians
- 3,423 contract staff and temporary employees
- 5,732 researchers-teachers and hospital teachers in Inserm units
Initial budget 2023
1.150 billion euros, of which:
- 62% corresponding to state subsidies (€707.4 million)
- 38% corresponding to internal resources (442.3 M€)
Learn more about Inserm
